03/21/2025
3:40 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
3:45 PM | Corbus Pharmaceuticals (Issuer)
Hodgson Ian (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/18/2025
3:30 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2025
4:24 PM | Corbus Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/11/2025
7:30 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
3:30 PM | Corbus Pharmaceuticals (Issuer)
Smethurst Dominic (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
3:30 PM | Corbus Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
3:16 PM | Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
7:05 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
6:48 PM | Corbus Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
5:41 PM | Corbus Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G | |
Get the Latest News and Ratings for CRBP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Corbus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
11/14/2024
2:09 PM | Corbus Pharmaceuticals (Subject)
Cormorant Asset Management, LP (Filed by)
| Form SC 13G/A | |
11/12/2024
1:34 PM | Corbus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/12/2024
8:37 AM | Adage Capital Management, L.P. (Filed by)
Corbus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/07/2024
3:58 PM | Corbus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
7:41 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
10:28 AM | Corbus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
6:51 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
Corbus Pharmaceuticals (Subject)
| Form SC 13G | |
10/15/2024
3:19 PM | Corbus Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
09/24/2024
3:04 PM | Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
3:44 PM | CATLIN AVERY W (Reporting)
Corbus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
3:52 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
3:45 PM | Corbus Pharmaceuticals (Issuer)
Kung Winston (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/20/2024
3:48 PM | Corbus Pharmaceuticals (Issuer)
Kung Winston (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
7:15 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
3:42 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
4:58 PM | Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
4:59 PM | Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
8:21 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
4:25 PM | Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:25 PM | Corbus Pharmaceuticals (Subject)
Moran Sean F. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
3:30 PM | Corbus Pharmaceuticals (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:31 PM | CATLIN AVERY W (Reporting)
Corbus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:32 PM | Corbus Pharmaceuticals (Issuer)
Jenkins John Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
6:08 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
3:39 PM | Corbus Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/20/2024
3:30 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
7:00 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
7:30 AM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
8:17 AM | Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Warning: “DOGE Collapse” imminent (Ad) Elon Strikes Back
You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead. Click here to see what they’re predicting now. |
04/10/2024
3:58 PM | Corbus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
3:59 PM | Corbus Pharmaceuticals (Filer)
| Form DEFA14A | |
